Mologic Platform Achieves Breakthrough for Ultrasensitive Point-of-Care Diagnostics
The visually read tests deliver up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts against global epidemics.
Read MorePosted by Chaunie Brusie | Jun 30, 2019 | Point-of-Care |
The visually read tests deliver up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts against global epidemics.
Read MorePosted by Chaunie Brusie | Jun 21, 2019 | Research |
Research suggests that C-reactive protein tests should be performed by general practitioners for results within minutes, rather than being performed by central laboratories.
Read MorePosted by Steve Halasey | May 27, 2019 | Molecular Diagnostics |
The innovative analyzers offer continuous random access for loading up to 288 patient samples for high-throughput sample processing, with a true operator walkaway window of up to 7 hours.
Read MorePosted by Steve Halasey | May 23, 2019 | Standards |
Developers are exploring the potential of blood biomarkers for traumatic brain injury.
Read MorePosted by Chaunie Brusie | Apr 21, 2019 | Point-of-Care |
The test quantitatively measures total PSA from a fingerstick of whole blood analyzed on the company’s Claros 1 benchtop analyzer.
Read More